Evaluating quality of care for patients with heart failure.
Krumholz
H M
HM
Baker
D W
DW
Ashton
C M
CM
Dunbar
S B
SB
Friesinger
G C
GC
Havranek
E P
EP
Hlatky
M A
MA
Konstam
M
M
Ordin
D L
DL
Pina
I L
IL
Pitt
B
B
Spertus
J A
JA
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy; D003625:Data Collection; D004077:Digoxin / Q000627:therapeutic use; D005081:Exercise Therapy; D018588:Fee-for-Service Plans / Q000706:statistics & numerical data; D006333:Heart Failure / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D007255:Information Services / Q000458:organization & administration; D007902:Length of Stay / Q000706:statistics & numerical data; D010043:Outcome and Process Assessment, Health Care / Q000379:methods; D010353:Patient Education as Topic / Q000458:organization & administration; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000592:standards; D011787:Quality of Health Care / Q000191:economics / Q000458:organization & administration*; D012017:Referral and Consultation / Q000458:organization & administration; D013318:Stroke Volume; D014481:United States; D018487:Ventricular Dysfunction, Left / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000925:Anticoagulants; D004077:Digoxin; D001241:Aspirin